GlassScriptPhysician profile
Derek C Mitchell
NPI 1437425535
$4,279.69
in general payments reported to CMS, 2019-2025
25 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,003 · 2020: $242 · 2021: $507 · 2022: $579 · 2023: $509 · 2024: $1,049 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193 · Travel and Lodging: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,192.54 |
| Travel and Lodging | $755.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,299.60 | 2021-2025 | Superion Indirect Decompression System, General - Pain Management, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $501.41 | 2019-2023 | Xtampza, Symproic |
| Daiichi Sankyo INC. | $344.35 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $271.54 | 2022-2025 | Dysport |
| Abbvie INC. | $266.13 | 2022-2023 | |
| Pacira Therapeutics, INC. | $252.40 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $193.86 | 2021-2023 | Relistor |
| Stimwave Technologies Incorporated | $190.67 | 2019 | |
| Lilly USA, LLC | $174.26 | 2019-2023 | Emgality |
| Allergan, INC. | $171.76 | 2020-2022 | |
| Biodelivery Sciences International, INC. | $88.51 | 2020-2021 | |
| Nevro Corp. | $72.85 | 2022 | |
| Si-Bone, INC. | $65.31 | 2023-2025 | |
| Pfizer INC. | $60.04 | 2023-2024 | |
| Merz Pharmaceuticals, LLC | $51.45 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $47.94 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.45 | 2022 | |
| Spr Therapeutics, INC | $40.73 | 2025 | Sprint Pns System |
| Bioventus LLC | $31.32 | 2019 | |
| Mdd US Operations, LLC | $24.67 | 2019 | |
| Abbott Laboratories | $21.81 | 2023 | Proclaim |
| Amgen INC. | $20.97 | 2022 | |
| Hikma Pharmaceuticals USA | $17.30 | 2022 | |
| Nalu Medical, INC. | $14.94 | 2023 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.